Elnaghi KA[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2023	1
2024	2

Page 1

Hormonal-Receptors-Positive and HER2-Negative Patients with Metastatic Breast Cancer Treated with First-Line Palbociclib and Hormonal Therapy: Impact of First-Cycle Neutropenia and Dose Reduction on Therapeutic Outcome.

Elnaghi KAEA, Alghanmi HA, Elsamany SA, Almarzoki F, Elsafty M, Jaffal M. Elnaghi KAEA, et al. Breast J. 2023 Aug 25;2023:8994954. doi: 10.1155/2023/8994954. eCollection 2023. Breast J. 2023. PMID: 37664544 Free PMC article.

Real-world treatment patterns and clinical outcomes in patients with prostate cancer.: A single institution experience in Saudi Arabia.

Khizanah RA, Tashkandi E, Jaffal M, Alsaedi M, Al-Ahmdi Y, Almehmadi A, Elnaghi KA. Khizanah RA, et al. Among authors: elnaghi ka. Saudi Med J. 2024 Jun;45(6):639-642. doi: 10.15537/smj.2024.45.6.20240042. Saudi Med J. 2024. PMID: 38830651 Free PMC article.

Reduced expression of SOX11 in colorectal adenocarcinoma is associated with mucinous and signet ring cell types, poor survival, and lower ALK expression.

Elkhamisy FAA, Eesa AN, Elnady OM, Elnaghi KAEA, Foda AAM. Elkhamisy FAA, et al. Among authors: elnaghi kaea. Pathol Res Pract. 2024 Aug;260:155450. doi: 10.1016/j.prp.2024.155450. Epub 2024 Jul 8. Pathol Res Pract. 2024. PMID: 38986363

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

3 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year